Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival-Reference-Cited by-同舟云学术

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

Published:2020-03-31 Issue:3 Volume:190 Page:394-404
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Martinez‐Calle Nicolás¹^ORCID,Poynton Edward²,Alchawaf Alia³,Kassam Shireen⁴^ORCID,Horan Matthew⁵,Rafferty Mark⁶^ORCID,Kelsey Phillipa⁷,Scott Gemma⁸,Culligan Dominic J.⁹,Buckley Hannah¹⁰,Lim Yeong J.¹¹,Ngu Loretta¹²,McCulloch Rory¹³^ORCID,Rowntree Clare⁸,Wright Josh⁷,McKay Pamela⁶^ORCID,Fourali Samih¹⁴,Eyre Toby A.¹⁴^ORCID,Smith Jeffrey¹¹,Osborne Wendy⁵,Yallop Deborah⁴,Linton Kim³,Fox Christopher P.¹^ORCID,Cwynarski Kate²

Affiliation:

1. Department of Clinical Haematology Nottingham University Hospitals NHS Trust Nottingham UK

2. University College of London Hospitals NHS Foundation Trust London UK

3. The Christie NHS Foundation Trust Manchester UK

4. King's College Hospital NHS Foundation Trust London UK

5. Newcastle Upon Tyne Hospitals NHS Trust Newcastle UK

6. Department of Haematology Beatson West of Scotland Cancer Centre Glasgow UK

7. Sheffield Teaching Hospitals NHS Trust Sheffield UK

8. University Hospital of Wales Cardiff UK

9. Aberdeen Royal Infirmary Aberdeen UK

10. Cambridge University Hospitals NHS Trust Cambridge UK

11. Aintree University Hospital NHS Trust Liverpool UK